Related references
Note: Only part of the references are listed.Enhancement of Cancer Vaccine Therapy by Systemic Delivery of a Tumor-Targeting Salmonella-Based STAT3 shRNA Suppresses the Growth of Established Melanoma Tumors
Edwin R. Manuel et al.
CANCER RESEARCH (2011)
Enhanced protection against nasopharyngeal carriage of Streptococcus pneumoniae elicited by oral multiantigen DNA vaccines delivered in attenuated Salmonella typhimurium
Qiao Zhang et al.
MOLECULAR BIOLOGY REPORTS (2011)
A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer
Alejandrina Vendrell et al.
VACCINE (2011)
Systematic Analysis of the SsrAB Virulon of Salmonella enterica
Xin Xu et al.
INFECTION AND IMMUNITY (2010)
Efficacy of Intracellular Activated Promoters for Generation of Salmonella-Based Vaccines
Xin Xu et al.
INFECTION AND IMMUNITY (2010)
Salmonella-allies in the fight against cancer
Sara Leschner et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Monotherapy with a Tumor-Targeting Mutant of S typhimurium Inhibits Liver Metastasis in a Mouse Model of Pancreatic Cancer
Clinton Yam et al.
JOURNAL OF SURGICAL RESEARCH (2010)
Live Recombinant Salmonella Typhi Vaccines Constructed to Investigate the Role of rpoS in Eliciting Immunity to a Heterologous Antigen
Huoying Shi et al.
PLOS ONE (2010)
Bacteria-Induced Gap Junctions in Tumors Favor Antigen Cross-Presentation and Antitumor Immunity
Fabiana Saccheri et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
New Technologies in Using Recombinant Attenuated Salmonella Vaccine Vectors
Roy Curtiss et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2010)
Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth
Markus Loeffler et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Survivin as a global target of intrinsic tumor suppression networks
Minakshi Guha et al.
CELL CYCLE (2009)
Potent anti-tumor activity of systemically-administered IL-2-expressing Salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis
Basel K. Al-Ramadi et al.
CLINICAL IMMUNOLOGY (2009)
Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors
R. M. Ryan et al.
GENE THERAPY (2009)
Salmonella enterica Serovar Typhimurium Strains with Regulated Delayed Attenuation In Vivo
Roy Curtiss et al.
INFECTION AND IMMUNITY (2009)
Regulated Delayed Expression of rfaH in an Attenuated Salmonella enterica Serovar Typhimurium Vaccine Enhances Immunogenicity of Outer Membrane Proteins and a Heterologous Antigen
Qingke Kong et al.
INFECTION AND IMMUNITY (2009)
New horizons in adjuvants for vaccine development
Steven G. Reed et al.
TRENDS IN IMMUNOLOGY (2009)
Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins
Mohamed I. Husseiny et al.
VACCINE (2009)
sopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria
Arvindhan G. Nagarajan et al.
VACCINE (2009)
Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines
Latha Pathangey et al.
VACCINE (2009)
IL-18-producing Salmonella inhibit tumor growth
M. Loeffler et al.
CANCER GENE THERAPY (2008)
Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy
Frank Friedlos et al.
CLINICAL CANCER RESEARCH (2008)
Intra-tumoral Salmonella typhimurium induces a systemic anti-tumor immune response that is directed by low-dose radiation to treat distal disease
Francesca Avogadri et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Genetic immunization -: Bacteria as DNA vaccine delivery vehicles
Pablo Daniel Becker et al.
HUMAN VACCINES (2008)
DNA vaccines: developing new strategies to enhance immune responses
Shaheed A. Abdulhaqq et al.
IMMUNOLOGIC RESEARCH (2008)
Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer
Hakim Echchannaoui et al.
INFECTION AND IMMUNITY (2008)
Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis
Wei Xin et al.
INFECTION AND IMMUNITY (2008)
Improving live attenuated bacterial carriers for vaccination and therapy
Holger Loessner et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Salmonella type III-mediated heterologous antigen delivery: A versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors
Klaus Panthel et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Rational design of Salmonella recombinant vaccines
Cedric Cheminay et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Attenuated Salmonella typhimurium with interleukin 2 gene prevents the establishment of pulmonary metastases in a model of osteosarcoma
Brent S. Sorenson et al.
JOURNAL OF PEDIATRIC SURGERY (2008)
Salmonellae interplay with host cells
Andrea Haraga et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment
Wei Kong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against trypanosoma cruzi
Silvia I. Cazorla et al.
INFECTION AND IMMUNITY (2008)
Tumor-targeting Salmonella typhimurium improves cyclophosphamide chemotherapy at maximum tolerated dose and low-dose metronomic regimens in a murine melanoma model
Li-Jun Jia et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth
Markus Loeffler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines:: A logical progression
Carol O. Tacket et al.
CLINICAL INFECTIOUS DISEASES (2007)
Using attenuated salmonella typhi as tumor targeting vector for MDR1 siRNA delivery - An experimental study
Zhongming Jiang et al.
CANCER BIOLOGY & THERAPY (2007)
Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis
Rachel W. Kasinskas et al.
CANCER RESEARCH (2007)
LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E-coli strains
C. Zhu et al.
VACCINE (2007)
Recombinant vaccines based on translocated effector proteins of Salmonella Pathogenicity Island 2
Mohamed I. Husseiny et al.
VACCINE (2007)
Colicins and their potential in cancer treatment
Lorna E. Lancaster et al.
BLOOD CELLS MOLECULES AND DISEASES (2007)
Synthesis and evaluation of an α-C-Galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells
Xuequan Lu et al.
CHEMBIOCHEM (2006)
The type III secretion injectisome
Guy R. Cornelis
NATURE REVIEWS MICROBIOLOGY (2006)
The use of clostridial spores for cancer treatment
S. Barbe et al.
JOURNAL OF APPLIED MICROBIOLOGY (2006)
Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro
Rachel W. Kasinskas et al.
BIOTECHNOLOGY AND BIOENGINEERING (2006)
An SopB-mediated immune escape mechanism of Salmonella enterica can be subverted to optimize the performance of live attenuated vaccine carrier strains
Claudia Link et al.
MICROBES AND INFECTION (2006)
Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71
Cheng-Hsun Chiu et al.
MICROBES AND INFECTION (2006)
Manipulating cellular transport and immune responses:: dynamic interactions between intracellular Salmonella enterica and its host cells
GL Abrahams et al.
CELLULAR MICROBIOLOGY (2006)
Salmonella type III secretion effectors:: pulling the host cell's strings
MC Schlumberger et al.
CURRENT OPINION IN MICROBIOLOGY (2006)
Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers
BD Kirkpatrick et al.
VACCINE (2006)
Enhanced therapeutic effect by combination of tumor-targeting Salmonella and endostatin in murine melanoma model
LJ Jia et al.
CANCER BIOLOGY & THERAPY (2005)
Immunobiology of muscle: advances in understanding an immunological microenvironment
H Wiendl et al.
TRENDS IN IMMUNOLOGY (2005)
The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium
E Berntman et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Evaluation of an intracellular-activated promoter for the generation of live Salmonella recombinant vaccines
MI Husseiny et al.
VACCINE (2005)
Antibiotic-free plasmid stabilization by operator-repressor titration for vaccine delivery by using live Salmonella entetica serovar Typhimurium
HS Garmory et al.
INFECTION AND IMMUNITY (2005)
Salmonella-mediated oral DNA vaccination using stabilized eukaryotic expression plasmids
H Bauer et al.
GENE THERAPY (2005)
Salmonella pathogenicity island 2-mediated overexpression of chimeric SspH2 proteins for simultaneous induction of antigen-specific CD4 and CD8 T cells
K Panthel et al.
INFECTION AND IMMUNITY (2005)
Inverted pathogenicity:: the use of pathogen-specific molecular mechanisms for prevention or therapy of disease
H Rüssmann
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2004)
Bacteria-mediated DNA transfer in gene therapy and vaccination
H Loessner et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Evolution of pathogenicity islands of Salmonella enterica
M Hensel
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2004)
Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1
D Baud et al.
JOURNAL OF VIROLOGY (2004)
Process of protein transport by the type III secretion system
P Ghosh
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2004)
Cellular microbiology of intracellular Salmonella enterica:: functions of the type III secretion system encoded by Salmonella pathogenicity island 2
V Kuhle et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Survivin: A bifunctional inhibitor of apoptosis protein
ME Johnson et al.
VETERINARY PATHOLOGY (2004)
Bacteria as DNA vaccine carriers for genetic immunization
C Schoen et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2004)
One size fits it all:: translocation of foreign antigens by Yersinia type III secretion system (TTSS) leads to concomitant CD4 and CD8 T-cell priming
H Rüssmann et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2004)
Mechanism of CD1d-restricted natural killer T cell activation during microbial infection
M Brigl et al.
NATURE IMMUNOLOGY (2003)
Intracellular activities of Salmonella enterica in murine dendritic cells
J Jantsch et al.
CELLULAR MICROBIOLOGY (2003)
Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system
SR Waterman et al.
CELLULAR MICROBIOLOGY (2003)
Bacterial type III translocation:: a unique mechanism for cytosolic display of heterologous antigens by attenuated Salmonella
H Rüssmann
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2003)
Continuous intravenous administration of live genetically modified Salmonella typhimurium in patients with metastatic melanoma
DM Heimann et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Induction of innate immunity by IL-2-expressing Salmonella confers protection against lethal infection
BK al-Ramadi et al.
MOLECULAR IMMUNOLOGY (2003)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
Concomitant cytosolic delivery of two immunodominant listerial antigens by Salmonella enterica serovar typhimurium confers superior protection against murine listeriosis
EI Igwe et al.
INFECTION AND IMMUNITY (2002)
DNA immunization using a secreted cell wall antigen Mp1p is protective against Penicillium marneffei infection
LP Wong et al.
VACCINE (2002)
Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers
Z Hindle et al.
INFECTION AND IMMUNITY (2002)
The global impact of vaccines containing aluminium adjuvants
CJ Clements et al.
VACCINE (2002)
Oral DNA vaccination: antigen uptake and presentation by dendritic cells elicits protective immunity
B Cochlovius et al.
IMMUNOLOGY LETTERS (2002)
Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma
JF Toso et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Mucosal and systemic HIV-1 Env-specific CD8+ T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector
MT Shata et al.
VACCINE (2001)
A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice
R Xiang et al.
JOURNAL OF IMMUNOLOGY (2001)
Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins
H Rüssmann et al.
JOURNAL OF IMMUNOLOGY (2001)
Salmonella pathogenicity islands encoding type III secretion systems
I Hansen-Wester et al.
MICROBES AND INFECTION (2001)
Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium
PCY Woo et al.
VACCINE (2001)
Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells
S Weiss et al.
BIOLOGICAL CHEMISTRY (2001)
Intracellular bacteria as targets and carriers for vaccination
H Mollenkopf et al.
BIOLOGICAL CHEMISTRY (2001)
A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA
EC Lee et al.
GENOMICS (2001)
Prophylactic tumor vaccination:: Comparison of effector mechanisms initiated by protein versus DNA vaccination
M Zöller et al.
JOURNAL OF IMMUNOLOGY (2001)
Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2a induced disease in mice
J Fló et al.
VACCINE (2001)
Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C
CO Tacket et al.
CLINICAL IMMUNOLOGY (2000)
Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid model
DM Monack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Salmonella pathogenicity island 2
M Hensel
MOLECULAR MICROBIOLOGY (2000)
Recombinant live Salmonella spp. for human vaccination against heterologous pathogens
D Bumann et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2000)
Salmonella infection of bone marrow-derived macrophages and dendritic cells:: influence on antigen presentation and initiating an immune response
U Yrlid et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2000)
Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers
H Angelakopoulos et al.
INFECTION AND IMMUNITY (2000)
Development of a nonantibiotic dominant marker for positively selecting expression plasmids in multivalent Salmonella vaccines
HV McNeill et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2000)
Share Paper
